Mammalian Target of Rapamycin (mTOR) Signaling at the Crossroad of Muscle Fiber Fate in Sarcopenia
Articolo
Data di Pubblicazione:
2022
Citazione:
Sirago, G., Picca, A., Calvani, R., Coelho-Junior, H. J., Marzetti, E., Mammalian Target of Rapamycin (mTOR) Signaling at the Crossroad of Muscle Fiber Fate in Sarcopenia, <>, 2022; 23 (22): 1-12. [doi:10.3390/ijms232213823] [https://hdl.handle.net/10807/223136]
Abstract:
The mammalian target of rapamycin (mTOR) is a major regulator of skeletal myocyte viability. The signaling pathways triggered by mTOR vary according to the type of endogenous and exogenous factors (e.g., redox balance, nutrient availability, physical activity) as well as organismal age. Here, we provide an overview of mTOR signaling in skeletal muscle, with a special focus on the role played by mTOR in the development of sarcopenia. Intervention strategies targeting mTOR in sarcopenia (e.g., supplementation of plant extracts, hormones, inorganic ions, calorie restriction, and exercise) have also been discussed.
Tipologia CRIS:
Articolo in rivista, Nota a sentenza
Keywords:
aging; atrogenes; autophagy; calorie restriction; mitophagy; neuromuscular junction; protein degradation; protein synthesis; rapalogs; skeletal muscle
Elenco autori:
Sirago, G.; Picca, A.; Calvani, Riccardo; Coelho-Junior, H. J.; Marzetti, Emanuele
Link alla scheda completa:
Link al Full Text:
Pubblicato in: